Literature DB >> 18066576

Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.

M Hedmer1, H Tinnerberg, A Axmon, B A G Jönsson.   

Abstract

OBJECTIVES: Exposure to antineoplastic drugs should be avoided due to the risk of getting adverse health effects. Antineoplastic drugs such as cyclophosphamide (CP) and ifosfamide (IF) are commonly used in medical attendance. In this study the variability of surface contamination of CP and IF was investigated by repeated wipe sampling over time in four workplaces in a university hospital. The surface contamination levels were also evaluated and health care workers were biologically monitored.
METHODS: A hospital pharmacy, two oncology wards and one oncology outpatient department were selected. Between 10 and 13 different surface areas such as work areas, floors and handles were selected in each workplace and wiped between 7 and 8 times during 9 months. Pre- and post-shift urine samples were collected from the workers in the investigated workplaces. Analysis was performed by liquid chromatography combined with tandem mass spectrometry.
RESULTS: Measurable amounts of CP and IF were detected on the majority of the sampled surfaces. The highest concentrations were found on the floors in the patient lavatories and utility rooms (up to 95 ng cm(-2)). In general, the surface contamination of CP and IF on floors did not vary much over time. Work areas and handles had larger variability. Neither CP nor IF were detected in any of the collected urine samples.
CONCLUSIONS: The variability in surface contamination of CP and IF was rather low especially on floors. Higher concentrations of CP and IF were found on the floors compared with the work areas. The highest surface loads were found on floors (in patient lavatories and utility rooms) that were related to patient activities such as handling of patients' urine. Although high contaminations were found, the biological monitoring showed no uptake. Wipe sampling is a good method to improve the work practices.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18066576     DOI: 10.1007/s00420-007-0284-y

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  51 in total

Review 1.  Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods.

Authors:  Roberta Turci; Cristina Sottani; Giuseppe Spagnoli; Claudio Minoia
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-06-15       Impact factor: 3.205

2.  Permeability of nitrile rubber, latex, polyurethane, and neoprene gloves to 18 antineoplastic drugs.

Authors:  T H Connor
Journal:  Am J Health Syst Pharm       Date:  1999-12-01       Impact factor: 2.637

3.  Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden.

Authors:  M Hedmer; A Georgiadi; E Rämme Bremberg; B A G Jönsson; S Eksborg
Journal:  Ann Occup Hyg       Date:  2005-08-26

4.  Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists.

Authors:  B Valanis; W M Vollmer; P Steele
Journal:  J Occup Environ Med       Date:  1999-08       Impact factor: 2.162

Review 5.  Metabolism and pharmacokinetics of oxazaphosphorines.

Authors:  A V Boddy; S M Yule
Journal:  Clin Pharmacokinet       Date:  2000-04       Impact factor: 6.447

6.  Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide.

Authors:  C T Evelo; R P Bos; J G Peters; P T Henderson
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

7.  Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.

Authors:  A S Ensslin; Y Stoll; A Pethran; A Pfaller; H Römmelt; G Fruhmann
Journal:  Occup Environ Med       Date:  1994-04       Impact factor: 4.402

8.  DNA damage in nurses handling antineoplastic agents.

Authors:  J Fuchs; J G Hengstler; D Jung; G Hiltl; J Konietzko; F Oesch
Journal:  Mutat Res       Date:  1995-03       Impact factor: 2.433

9.  Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.

Authors:  Maria Hedmer; Peter Höglund; Eva Cavallin-Ståhl; Maria Albin; Bo A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-06-20       Impact factor: 3.015

10.  Occupational exposure to cytotoxic drugs in two UK oncology wards.

Authors:  E Ziegler; Howard J Mason; P J Baxter
Journal:  Occup Environ Med       Date:  2002-09       Impact factor: 4.402

View more
  19 in total

1.  Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings.

Authors:  Bettina Kopp; Rudolf Schierl; Dennis Nowak
Journal:  Int Arch Occup Environ Health       Date:  2012-02-05       Impact factor: 3.015

2.  Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals.

Authors:  Delphine Merger; Cynthia Tanguay; Eric Langlois; Michel Lefebvre; Jean-François Bussières
Journal:  Int Arch Occup Environ Health       Date:  2013-03-08       Impact factor: 3.015

3.  Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.

Authors:  Susana Viegas; Mário Pádua; Ana Costa Veiga; Elisabete Carolino; Mário Gomes
Journal:  Environ Monit Assess       Date:  2014-08-06       Impact factor: 2.513

Review 4.  Applicability of the comet assay in evaluation of DNA damage in healthcare providers' working with antineoplastic drugs: a systematic review and meta-analysis.

Authors:  Mohammad Javad Zare Sakhvidi; Mohammad Hajaghazadeh; Mehrdad Mostaghaci; Amir Houshang Mehrparvar; Fariba Zare Sakhvidi; Elham Naghshineh
Journal:  Int J Occup Environ Health       Date:  2016-04-25

5.  Antineoplastic drug contamination in the urine of Canadian healthcare workers.

Authors:  Chun-Yip Hon; Kay Teschke; Hui Shen; Paul A Demers; Scott Venners
Journal:  Int Arch Occup Environ Health       Date:  2015-01-28       Impact factor: 3.015

6.  Application of an innovative high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous analysis of 18 hazardous drugs to rule out accidental acute chemotherapy exposures in health care workers.

Authors:  Pan Shu; Ting Zhao; Bo Wen; Kari Mendelsohn-Victor; Duxin Sun; Christopher R Friese; Manjunath P Pai
Journal:  J Oncol Pharm Pract       Date:  2019-09-04       Impact factor: 1.809

7.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03

8.  Antineoplastic drug exposure in an ambulatory setting: a pilot study.

Authors:  Christopher R Friese; Cristin McArdle; Ting Zhao; Duxin Sun; Ivan Spasojevic; Martha Polovich; Marjorie C McCullagh
Journal:  Cancer Nurs       Date:  2015 Mar-Apr       Impact factor: 2.592

9.  Evaluating Six Commercially Available Closed-System Drug-Transfer Devices Against NIOSH's 2015 Draft Vapor Protocol.

Authors:  Shiraz Halloush; Ivan A Reveles; Jim Koeller
Journal:  Hosp Pharm       Date:  2019-06-06

Review 10.  Cytostatics in Indoor Environment: An Update of Analytical Methods.

Authors:  M Francisca Portilha-Cunha; A Alves; Mónica S F Santos
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.